| Literature DB >> 24590025 |
Timothy J Whitmore1, John P O'Shea2, Diana Starac3, Mark G Edwards4, Grant W Waterer5.
Abstract
We report a case of significant pulmonary hemorrhage developing shortly after commencing ticagrelor and aspirin therapy and requiring coronary artery bypass grafting to safely cease the antiplatelet therapy. Lung biopsy findings were consistent with drug-induced lung injury. Clinicians should be aware of this significant adverse event with this drug class.Entities:
Mesh：
Substances：
Year: 2014 PMID： 24590025 DOI： 10.1378/chest.13-1502
Source DB: PubMed Journal: Chest ISSN： 0012-3692 Impact factor: 9.410